2-{2-[3-(4-chlorophenyl)-5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide
Chemical Structure Depiction of
2-{2-[3-(4-chlorophenyl)-5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide
2-{2-[3-(4-chlorophenyl)-5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide
Compound characteristics
Compound ID: | E239-0181 |
Compound Name: | 2-{2-[3-(4-chlorophenyl)-5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide |
Molecular Weight: | 519.02 |
Molecular Formula: | C27 H23 Cl N4 O3 S |
Smiles: | COc1ccc(cc1)C1CC(c2ccc(cc2)[Cl])=NN1C1=NC(C(CC(Nc2ccccc2)=O)S1)=O |
Stereo: | MIXTURE OF STEREOISOMERS |
logP: | 5.3951 |
logD: | 5.395 |
logSw: | -6.2174 |
Hydrogen bond acceptors count: | 8 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 66.516 |
InChI Key: | MBRKDKZRVJJSIC-UHFFFAOYSA-N |